Corvus Pharmaceuticals, Inc. short interest in 2025
In 2025, Corvus Pharmaceuticals, Inc.'s disclosed short interest ran from 8.56% of shares outstanding on 15 Jan 2025 to 15.82% on 31 Dec 2025, a change of +7.26 percentage points. The year's high was 15.82% on 31 Dec 2025 and its low 7.22% on 31 Mar 2025, averaging 11.24% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.79 days on 31 Jul 2025. Full history: Corvus Pharmaceuticals, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 8.56% (15 Jan 2025)
- End of year
- 15.82% (31 Dec 2025)
- Change
- +7.26 pp
- High
- 15.82% (31 Dec 2025)
- Low
- 7.22% (31 Mar 2025)
- Average
- 11.24%
- Highest days to cover
- 19.79 (31 Jul 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 8.56% | 8.48 | |
| 31 Jan 2025 | 9.51% | 13.80 | |
| 14 Feb 2025 | 8.92% | 15.21 | |
| 28 Feb 2025 | 8.32% | 7.28 | |
| 14 Mar 2025 | 8.39% | 9.49 | |
| 31 Mar 2025 | 7.22% | 6.13 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 7.84% | 6.47 | |
| 30 Apr 2025 | 8.47% | 5.96 | |
| 15 May 2025 | 10.61% | 3.59 | 10-Q filed, results (8-K) |
| 30 May 2025 | 10.39% | 10.75 | |
| 13 Jun 2025 | 11.65% | 8.82 | |
| 30 Jun 2025 | 13.07% | 5.81 | |
| 15 Jul 2025 | 13.19% | 15.86 | |
| 31 Jul 2025 | 12.90% | 19.79 | |
| 15 Aug 2025 | 12.47% | 18.81 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 12.88% | 17.60 | |
| 15 Sep 2025 | 12.98% | 15.37 | |
| 30 Sep 2025 | 13.55% | 12.64 | |
| 15 Oct 2025 | 11.85% | 7.85 | |
| 31 Oct 2025 | 12.12% | 8.88 | |
| 14 Nov 2025 | 13.26% | 8.72 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 13.14% | 12.97 | |
| 15 Dec 2025 | 12.56% | 6.71 | |
| 31 Dec 2025 | 15.82% | 6.47 |
See also: Corvus Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.